Story perspectives

Novartis Commits $23 Billion, Creates 4,000 U.S. Jobs

4/10/2025

47 11

Summary

Novartis Expands Investment

Novartis will invest $23 billion in 10 U.S. facilities over five years, including six new manufacturing plants.
The investment is expected to generate over 4,000 jobs, with 1,000 positions at Novartis.
This decision comes amid tariff threats on pharmaceuticals, though Novartis' CEO downplayed their influence.
Eli Lilly and Johnson & Johnson have also announced major investments in the U.S. recently.

Summary

Trump Proposes Tariffs

President Trump proposed significant tariffs on pharmaceuticals, raising alarms for drug manufacturers and patients.
European and Indian firms may incur substantial losses, potentially affecting drug availability in the U.S.
The European Federation of Pharmaceutical Industries indicated a possible shift in investment from Europe to the U.S.
Eli Lilly's CEO warned that tariffs could reduce research and development funding, hindering future drug innovation.
Ongoing tariff uncertainty is creating volatility in global pharmaceutical stocks and investment strategies.

1 of 2

Novartis Expands Investment

Novartis will invest $23 billion in 10 U.S. facilities over five years, including six new manufacturing plants.
The investment is expected to generate over 4,000 jobs, with 1,000 positions at Novartis.
This decision comes amid tariff threats on pharmaceuticals, though Novartis' CEO downplayed their influence.
Eli Lilly and Johnson & Johnson have also announced major investments in the U.S. recently.

1 / 2